Randomized, open-label study of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small cell lung cancer (NSCLC) of nonsquamous histology.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. TPS290-TPS290 ◽  
Author(s):  
R. Zinner ◽  
S. Saxman ◽  
G. Peng ◽  
W. F. Ortuzar
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Updated results from TIGER-X, a phase I/II open label study of rociletinib in patients (pts) with advanced, recurrent T790M-positive non-small cell lung cancer (NSCLC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9045-9045 ◽  
Author(s):  
Jonathan Wade Goldman ◽  
Jean-Charles Soria ◽  
Heather A. Wakelee ◽  
D. Ross Camidge ◽  
Shirish M. Gadgeel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Biomarker analyses from an open-label study of erlotinib in advanced non-small-cell lung cancer (NSCLC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 19012-19012
Author(s):  
N. van Zandwijk ◽  
W. Su ◽  
R. Rooneem ◽  
B. Mehi|Dc ◽  
F. A. Franke
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancer

2009 ◽  
Vol 20 (3) ◽  
pp. 486-491 ◽  
Author(s):  
R. de Boer ◽  
Y. Humblet ◽  
J. Wolf ◽  
L. Nogová ◽  
K. Ruffert ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document